241 related articles for article (PubMed ID: 21752305)
1. Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach.
Patronov A; Dimitrov I; Flower DR; Doytchinova I
BMC Struct Biol; 2011 Jul; 11():32. PubMed ID: 21752305
[TBL] [Abstract][Full Text] [Related]
2. Peptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: a quantitative molecular docking study.
Patronov A; Dimitrov I; Flower DR; Doytchinova I
BMC Struct Biol; 2012 Aug; 12():20. PubMed ID: 22862845
[TBL] [Abstract][Full Text] [Related]
3. HLA-DP2 binding prediction by molecular dynamics simulations.
Doytchinova I; Petkov P; Dimitrov I; Atanasova M; Flower DR
Protein Sci; 2011 Nov; 20(11):1918-28. PubMed ID: 21898654
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of HLA-DP2 and implications for chronic beryllium disease.
Dai S; Murphy GA; Crawford F; Mack DG; Falta MT; Marrack P; Kappler JW; Fontenot AP
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7425-30. PubMed ID: 20356827
[TBL] [Abstract][Full Text] [Related]
5. Peptide binding predictions for HLA DR, DP and DQ molecules.
Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
[TBL] [Abstract][Full Text] [Related]
6. Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.
Díaz G; Cañas B; Vazquez J; Nombela C; Arroyo J
Immunogenetics; 2005 Jan; 56(10):754-9. PubMed ID: 15565337
[TBL] [Abstract][Full Text] [Related]
7. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
Bordner AJ; Mittelmann HD
BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
[TBL] [Abstract][Full Text] [Related]
8. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
9. Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity.
Berretta F; Butler RH; Diaz G; Sanarico N; Arroyo J; Fraziano M; Aichinger G; Wucherpfennig KW; Colizzi V; Saltini C; Amicosante M
Tissue Antigens; 2003 Dec; 62(6):459-71. PubMed ID: 14617029
[TBL] [Abstract][Full Text] [Related]
10. The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.
Hansen BE; Nielsen CH; Madsen HO; Ryder LP; Jakobsen BK; Svejgaard A
Tissue Antigens; 2011 Mar; 77(3):229-34. PubMed ID: 21299528
[TBL] [Abstract][Full Text] [Related]
11. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
Bordner AJ
PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
[TBL] [Abstract][Full Text] [Related]
12. Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.
Fontenot AP; Keizer TS; McCleskey M; Mack DG; Meza-Romero R; Huan J; Edwards DM; Chou YK; Vandenbark AA; Scott B; Burrows GG
J Immunol; 2006 Sep; 177(6):3874-83. PubMed ID: 16951350
[TBL] [Abstract][Full Text] [Related]
13. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
Nielsen M; Lundegaard C; Lund O
BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
[TBL] [Abstract][Full Text] [Related]
14. HLA-DP2: self peptide sequences and binding properties.
Chicz RM; Graziano DF; Trucco M; Strominger JL; Gorga JC
J Immunol; 1997 Nov; 159(10):4935-42. PubMed ID: 9366419
[TBL] [Abstract][Full Text] [Related]
15. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
[TBL] [Abstract][Full Text] [Related]
16. Chronic Beryllium Disease: revealing the role of beryllium ion and small peptides binding to HLA-DP2.
Petukh M; Wu B; Stefl S; Smith N; Hyde-Volpe D; Wang L; Alexov E
PLoS One; 2014; 9(11):e111604. PubMed ID: 25369028
[TBL] [Abstract][Full Text] [Related]
17. Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.
Mazor R; Addissie S; Jang Y; Tai CH; Rose J; Hakim F; Pastan I
AAPS J; 2017 Jan; 19(1):117-129. PubMed ID: 27796910
[TBL] [Abstract][Full Text] [Related]
18. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.
Castelli FA; Buhot C; Sanson A; Zarour H; Pouvelle-Moratille S; Nonn C; Gahery-Ségard H; Guillet JG; Ménez A; Georges B; Maillère B
J Immunol; 2002 Dec; 169(12):6928-34. PubMed ID: 12471126
[TBL] [Abstract][Full Text] [Related]
19. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.
Ovsyannikova IG; Vierkant RA; Poland GA
Vaccine; 2006 Jun; 24(25):5381-9. PubMed ID: 16714073
[TBL] [Abstract][Full Text] [Related]
20. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.
Greenbaum J; Sidney J; Chung J; Brander C; Peters B; Sette A
Immunogenetics; 2011 Jun; 63(6):325-35. PubMed ID: 21305276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
